Literature DB >> 11214094

Chloroquine prophylaxis, iron/folic-acid supplementation or case management of malaria attacks in primigravidae in western Uganda: effects on congenital malaria and infant haemoglobin concentrations.

R Ndyomugyenyi1, P Magnussen.   

Abstract

A randomized, double-blind, placebo-controlled trial, which compared the effects of three interventions (weekly chloroquine prophylaxis, daily iron and weekly folic-acid supplementation, and case management of malaria) on congenital malaria, maternal haemoglobin (Hb) and foetal outcome, was conducted among primigravidae resident in Hoima district, Uganda. Among 473 babies examined at birth or within 7 days of birth, 198 (42%) were parasitaemic, the level of parasitaemia in an infant being strongly correlated with those of placental (P< 0.01) and maternal, peripheral parasitaemia (P < 0.01). However, 33 (17%) of the parasitaemic babies were born to mothers who had placental but not peripheral parasitaemia, 22 (11%) to mothers who had peripheral but not placental parasitaemia, and 12 (6%) to mothers with neither peripheral nor placental parasitaemia. Overall, 163 babies were each examined for malarial parasites at birth and 1 month later. Of the 76 (47%) found to have parasitaemia at birth, 37 (23%) appeared aparasitaemic at the 1-month follow-up but 28 (17%) were still parasitaemic at that time. Among the babies born to the mothers who only received case management of malaria during pregnancy, parasitaemia at birth was associated with infant anaemia at birth (i.e. < 140 g Hb/litre; P = 0.03). Infants found to be parasitaemic at the 1-month follow-up had lower mean concentrations of Hb at that time than their aparasitaemic counterparts (P= 0.03). Parasitaemia at birth was not significantly associated with low birthweight, in any of three intervention groups. The intervention given to the mother had no significant effect on the parasitaemia of her baby, either at birth or at the age of 1 month. Congenital malaria per se may have little influence on birthweight but may have an impact on infant anaemia. In conclusion, congenital parasitaemia was not associated with birthweight, but was related to anaemia at birth in infants born to women who had only received active case management during their pregnancies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11214094     DOI: 10.1080/00034980020015189

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  17 in total

1.  Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.

Authors:  Nana O Wilson; Fatou K Ceesay; Samuel A Obed; Andrew A Adjei; Richard K Gyasi; Patricia Rodney; Yassa Ndjakani; Winston A Anderson; Naomi W Lucchi; Jonathan K Stiles
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

2.  Neonatal Malaria: Report of two Cases.

Authors:  C Vidyashankar; R K Choudhary; Shobana Das
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  A pragmatic randomised controlled trial on routine iron prophylaxis during pregnancy in Maputo, Mozambique (PROFEG): rationale, design, and success.

Authors:  Bright I Nwaru; Saara Parkkali; Fatima Abacassamo; Graca Salomé; Baltazar Chilundo; Orvalho Augusto; Julie Cliff; Martinho Dgedge; Elena Regushevskaya; Minna Nikula; Elina Hemminki
Journal:  Matern Child Nutr       Date:  2012-10-01       Impact factor: 3.092

4.  Malaria prevention with IPTp during pregnancy reduces neonatal mortality.

Authors:  Clara Menéndez; Azucena Bardají; Betuel Sigauque; Sergi Sanz; John J Aponte; Samuel Mabunda; Pedro L Alonso
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

5.  Congenital and neonatal malaria in a rural Kenyan district hospital: an eight-year analysis.

Authors:  Michael K Mwaniki; Alison W Talbert; Florence N Mturi; James A Berkley; Piet Kager; Kevin Marsh; Charles R Newton
Journal:  Malar J       Date:  2010-11-06       Impact factor: 2.979

Review 6.  Drugs for treating uncomplicated malaria in pregnant women.

Authors:  Lois C Orton; Aika A A Omari
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 7.  Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment.

Authors:  Denitsa Radeva-Petrova; Kassoum Kayentao; Feiko O ter Kuile; David Sinclair; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2014-10-10

Review 8.  Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis.

Authors:  Batool A Haider; Ibironke Olofin; Molin Wang; Donna Spiegelman; Majid Ezzati; Wafaie W Fawzi
Journal:  BMJ       Date:  2013-06-21

9.  Impact of malaria at the end of pregnancy on infant mortality and morbidity.

Authors:  Azucena Bardají; Betuel Sigauque; Sergi Sanz; María Maixenchs; Jaume Ordi; John J Aponte; Samuel Mabunda; Pedro L Alonso; Clara Menéndez
Journal:  J Infect Dis       Date:  2011-01-03       Impact factor: 5.226

10.  Comparison of routine prenatal iron prophylaxis and screening and treatment for anaemia: pregnancy results and preliminary birth results from a pragmatic randomised controlled trial (PROFEG) in Maputo, Mozambique.

Authors:  Saara Parkkali; Fatima Abacassamo; Bright Ibeabughichi Nwaru; Graca Salomé; Orvalho Augusto; Elena Regushevskaya; Martinho Dgedge; Cesar Sousa; Julie Cliff; Baltazar Chilundo; Elina Hemminki
Journal:  BMJ Open       Date:  2013-02-08       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.